Fauci, NIAID Helped Fund Army Experiment With Aerosolized Ebola
Newly released records from a U.S. Senate investigation show that the National Institute of Allergy and Infectious Diseases (NIAID) paid for and helped plan U.S. Army research in which vaccinated nonhuman primates were exposed to aerosolized Ebola virus.1 The work took place while Anthony Fauci, MD directed the agency, a post he held for 38 […]
Florida AG Sues Pfizer and CEO, Alleging COVID Shot Safety Risks Were Concealed
Florida Attorney General James Uthmeier filed suit against Pfizer, Inc. and its chief executive, Albert Bourla on Oct. 1, 2026. The complaint alleges the defendants violated the Florida Deceptive and Unfair Trade Practices Act (FDUTPA).1 2 The 49-page complaint filed in the Circuit Court of the Nineteenth Judicial Circuit in St. Lucie County describes a […]
GLP-1 Drugs Named in Dozens of Lawsuits Alleging Permanent Vision Loss
Dozens of patients have filed personal injury lawsuits against GLP-1 manufacturers, Eli Lilly and Novo Nordisk, alleging that the drugs caused permanent damage to their vision. The complaints, filed over the past year, point to a condition called non-arteritic anterior ischemic optic neuropathy, or NAION, which occurs when there is insufficient blood flow to the […]
NIH to Launch Research Center on Vaccine Injuries
The U.S. National Institutes of Health (NIH) will launch a clinical research program and dedicated center to study individuals who were harmed by vaccines, including COVID-19 shots. Officials at the National Institute of Allergy and Infectious Diseases (NIAID) discussed establishing the research center at the NIH campus in Bethesda, Maryland, with the program potentially beginning […]
Tamiflu Found to Be Ineffective, May Increase Mortality in Patients Critically Ill With Influenza
A randomized clinical trial posted as a preprint on July 27, 2026, found that treatment with oseltamivir, commonly known by the brand name Tamiflu, is not only ineffective, but highly likely to increase 90-day mortality in critically ill patients with influenza. Researchers enrolled 442 critically ill patients aged 12 and older with laboratory-confirmed influenza between […]
FDA’s Botched Review of Moderna’s Flu mRNA Vaccine
When the FDA licensed Moderna’s new mRNA flu vaccine [earlier this month], legacy media coverage focused almost exclusively on efficacy. The pivotal trial reported that the vaccine was “26.6% more effective” than a conventional flu vaccine at preventing protocol-defined influenza-like illness. What received far less scrutiny was a much more serious problem in the trial […]